OBJECTIVE: To examine whether fasting insulin concentrations and markers of ®rst-phase insulin secretion are associated with weight gain and changes in distribution of adiposity over 4.4 y. DESIGN: Longitudinal prospective population-based cohort study of middle-aged Caucasians. SUBJECTS: 767 subjects (40 ± 65 y at baseline) were followed up for a mean of 4.4 y. MEASUREMENTS: 75 g oral glucose tolerance test performed at baseline and follow-up. Insulin was measured at fasting, and 30 and 120 min post-glucose load using a highly speci®c assay. RESULTS: Fasting insulin levels were correlated with baseline weight (r 0.32, P`0.001), as was the 30 min insulin incremental response (r 0.17, P`0.001). Mean weight gain over the 4.4 y of follow-up was 2.17 kg (range: 7 6.17 ± 10.5 kg) for men and 2.49 kg (range: 7 7.41 ± 12.39 kg) for women. In women, the 30 min insulin incremental response was negatively associated with percentage weight gain (P`0.001), but there was no relationship between fasting insulin levels and weight gain. The baseline fasting insulin was positively correlated with percentage increase in waist ± hip ratio (r 0.12, P 0.01). In strati®ed analysis, this relationship was con®ned to women over the age of 50 y. However, in men, none of these relationships were demonstrable. CONCLUSION: In middle-aged women reduced ®rst-phase insulin secretion was associated with an increased risk of future weight gain, whereas fasting hyperinsulinaemia was associated with an increase in waist ± hip ratio over time.
Introduction
Cross-sectional relationships between insulin resistance, insulin secretion and weight have been well described. 1 ± 8 It is recognised in a variety of populations that insulin resistance and insulin secretion are positively correlated with weight in subjects with normal glucose tolerance. Despite this, a consensus regarding the longitudinal relationships between weight and insulin resistance and secretion has yet to be reached. 9 Three prospective studies in Mexican Indians, Hispanic and non-Hispanic Whites and Pima Indians have shown an inverse relationship between fasting insulin and future weight gain, especially for those subjects with highest initial weight, 10, 11, 12 suggesting that hyperinsulinaemia, a re¯ection of insulin resistance, may act to limit future weight gain. 13 No such relationship was found in a prospective study of Mauritians, after adjusting for initial body mass index. 14 Few studies have addressed the relationship between insulin secretion and future weight gain. A prospective study of adult Pima Indians demonstrated an inverse relationship between increased insulin secretion at baseline and rates of weight gain. 15 Contrary to this, a prospective study using the adult glucose-tolerant offspring of two parents with type 2 diabetes mellitus found a high ®rst-phase insulin response to intravenous glucose to be a risk factor for weight gain. 16 To our knowledge there have been no prospective studies in a European population addressing these two issues and there are few studies which link these metabolic parameters to changes in regional adiposity. We, therefore, wished to address whether markers of insulin resistance and insulin secretion predicted weight gain or changes in distribution of adiposity in a population of middle-aged Caucasian people with normal glucose tolerance. These individuals form part of the cohort of people currently taking part in a prospective study of type 2 diabetes mellitus and related metabolic disorders.
Methods

Sample
The study participants were from Ely in Cambridgeshire, UK. They were taking part in a population-based cohort study consisting of 1122 people aged 40 ± 64 y, from an initial randomly selected sample of 1571. Selection, methods and biochemical analyses have been described elsewhere. 17, 18 Brie¯y, subjects attended for a standard 75 g oral glucose tolerance test after a 10 h overnight fast. Plasma glucose was measured using the hexokinase method. 19 Insulin was measured using a highly speci®c two-site immunoradiometric assay. 20 Inter-assay coef®cient of variation of the insulin measurements was less than 10%. An additional sample was taken at 30 min post-glucose load to allow calculation of the 30 min insulin incremental response. This measure, (30 min insulin 7 fasting insulin)a(30 min glucose), has been shown to correlate well with the 3 min insulin during an intravenous glucose tolerance test 21, 22 and is used in this study as a measure of ®rst-phase insulin secretion. Fasting insulin is used in the analysis as a measure of insulin resistance, because previous studies have demonstrated a strong correlation between fasting insulin and more precise measures of insulin resistance, particular within the glucose tolerance category. 23 Weight, height and waist ± hip ratio (WHR) were measured using standard techniques. 17, 18, 24 In 1994 a follow-up study was commenced. 18 All subjects were invited to re-attend for a 75 g oral glucose tolerance test and all other measurements were repeated. Changes in weight and waist ± hip ratio from baseline were expressed as a percentage to represent physiological change. Two trained observers using the same equipment for both the baseline and follow-up studies performed all measurements. Ethical permission for the study was granted by the Cambridge District Ethical Committee and informed written consent was obtained from each participant before the start of the study.
Statistical analyses
Data were analysed in SPSS for Windows (version 6.1). Anthropometric variables measured at baseline and follow-up were compared using a paired t-test. The results are reported as the mean of the paired difference with its 95% con®dence interval.
Results
In all, 1122 participants agreed to take part in the initial study, of whom 51 had type 2 diabetes mellitus and 188 had impaired glucose tolerance by WHO criteria. 25 The analyses reported in this paper are restricted to the 883 subjects with normal glucose tolerance at baseline. Of the initial 883 subjects, 767 (87%) attended for the follow-up study. Baseline and follow-up anthropometric measurements are shown in Table 1 . The mean follow-up time was 4.4 y for both men and women. There was no signi®cant difference in weight gain between the sexes: 2.49 kg for women compared with 2.17 kg for men (P 0.336). Men had a greater increase in waist ± hip ratio (WHR) than women (P 0.004), and the increase in WHR correlated with gain in weight in both sexes (analysis of variance for linearity in men, r 0.36, P`0.001, and women r 0.18, P`0.001, see Figure 1 ). Change in weight in both men and women and change in waist circumference in women were signi®cantly and negatively correlated with age, as shown in Table 2 . Hip circumference in men of all ages declined over the 4.4 y of the study, and this loss was greater in older men. Women generally gained in hip circumference, but this was negatively correlated with baseline age and those women over 60 years of age at baseline had a mean decrease in hip size. Further analyses were adjusted for baseline age. At baseline, fasting insulin Insulin and regional adiposity AJ Gould et al levels and 30 min insulin incremental response correlated positively with weight (r 0.32 and r 0.17, respectively, P`0.001). There was no relationship observed between quartiles of fasting insulin concentration and rates of weight gain (P for linear trend 0.30). Analysis of the genders separately did not reveal any relationship between fasting or 120 min insulin and weight gain (see Table 3 ). Neither was there any relationship between fasting insulin and change in WHR in men. However, in women, there was a signi®cant positive relationship between both fasting insulin and increase in WHR, as shown in Figure 2 . When strati®ed by age, the positive relationship between fasting insulin and increase in WHR was found to be con®ned to women over the age of 50 y (P 0.007), and there was no signi®cant association in those aged less than 50 y. Quartiles of 30 min insulin incremental response following an oral glucose load correlated negatively with percentage weight change between the two phases of the study (P for linear trend 0.01). However, this relationship was found to be entirely restricted to women (see Figure 3 , P for linear trend`0.001). There was no relationship between the 30 min insulin incremental response and change in WHR in either gender after controlling for age, and no relationship between baseline metabolic parameters and change in waist circumference. 
Insulin and regional adiposity AJ Gould et al
Discussion
This study has shown that a lower ®rst-phase insulin response, as measured by the 30 min insulin incremental response following an oral glucose tolerance test, is associated with increased overall weight gain in women. A reduced ®rst-phase insulin response is not associated with an increase in intra-abdominal fat, measured by the change in WHR, as might be expected given that increased weight is associated with increased WHR. The other main ®nding of this study is that fasting insulin level was associated with increases in WHR over time in women aged 50 y or over, whereas there was no such relationship in men. There was no relationship between baseline insulin levels and degree of overall weight gain in either women or men. This suggests that those women who were insulin resistant at baseline gained more intraabdominal fat than their more insulin-sensitive counterparts, although the amount of weight they gained overall was no different. This could explain a change to a more android-type shape, which has previously been associated with insulin resistance. High waist ± hip ratios and increases in visceral fat mass, independent of total fat mass, have been associated with excess cardiovascular disease, stroke, deterioration in measures of plasma glucose ± insulin homeostasis and mortality in women. 26, 27 The relationship between markers of baseline insulin resistance and the subsequent development of abdominal obesity in women has not been reported previously. The ®nding of a poor ®rst-phase insulin response predicting weight gain has been shown in adult Pima Indians. 15 Unfortunately, the sample size in that study did not allow for the separate analysis of men and women. The result from our study con¯icts with that from a recent prospective study of 107 glucose-tolerant offspring of type 2 diabetic parents, in whom the acute secretion of insulin correlated positively with rates of weight gain. 16 However, the data were not analysed separately by sex and the sample population was much more homogeneous than the Ely population, being as a group very insulin resistant. The positive relationship between baseline weight and fasting insulin concentration demonstrated in this population is consistent with other populationbased studies. 3 ± 9 The lack of a relationship between fasting insulin measured at baseline and future overall weight gain parallels ®ndings in the Asian Indians and Creole Mauritians, in whom the weak negative relationships between fasting insulin and weight gain or change in WHR were rendered non-signi®cant when adjustment was made for baseline age and body mass index (BMI). 14 It is interesting that, in this latter study, the crude correlation between fasting insulin and change in WHR was stronger in women than men. In a recent report from the CARDIA study cohort, fasting insulin was positively associated with ageadjusted weight gain in whites and black men, but this relationship disappeared when adjusted for baseline weight. 28 This was a study of young adults (mean age 25) who were generally not overweight. A previous study also reported a positive relationship between fasting insulin and weight gain in Chinese men, and this relationship strengthened when adjusted for BMI.
14 A positive relationship between fasting hyperinsulinaemia and future obesity has also been documented in prepubertal Pima Indian children. 29 Other studies, performed to look prospectively at the link between insulin resistance and obesity, have found that, instead of promoting weight gain, insulin resistance was signi®cantly correlated with reduced rates of weight gain in Pima Indians, the San Antonio and the San Luis Valley studies, and in follow-up of the ARIC study cohort. 10 ± 12,28 In this latter study, the negative association was stronger in white and black women than in white men and there was no association in black men. Waist ± hip measurements were not reported. Inconsistencies in results from these studies may be due in part to differences in subject characteristics, especially the age ranges of the cohorts, gender and ethnicity.
Our study was consistent with these previous studies in con®rming a strong, negative relationship between age and weight gain. We have also demonstrated that in Caucasian, middle-aged adults, age is negatively correlated with weight gain and positively correlated with loss of height in men and women, and positively correlated with reduction in hip size in men. Age is also negatively correlated with change in waist and hip circumference in women. It is possible that factors affecting overall weight gain and regional fat deposition have different effects in younger and older women. After the menopause, women increase deposition of intra-abdominal fat and this change in the site of fat deposition has been shown in some, but not all studies to be affected by the use of hormone replacement therapy (HRT). 30, 31 It is unknown whether the use of HRT would modify the predicted gain in abdominal fat in insulin-resistant women in this population. As this relationship was limited to women aged 50 and over, it may have been in¯uenced by menopausal status. Unfortunately, this information was unavailable and it is not known what proportion of these women might have been on HRT. In this study the age range was more restricted and generally higher than other previously reported studies, and the mean baseline BMI was lower and typical of a Caucasian European population. The majority of previous studies have not reported data on follow-up measurements of WHR and so it is impossible to say whether the relationship between fasting insulin levels and increases in WHR in women would be similar in different ethnic groups of the same age range.
The mechanisms by which insulin secretion relates to weight gain, and fasting hyperinsulinaemia to the distribution of obesity, are unknown. Insulin has been under investigation as being a satiety factor for many years. It has been shown to have a direct effect on the Insulin and regional adiposity AJ Gould et al hypothalamus, 32 but it is not known how important this mechanism is in the control of appetite. A recent study of obese women reported that there was no relationship with fasting levels of metabolic parameters, including insulin, and ratings of hunger. However, postprandial insulin levels were an independent predictor of satiety. 33 This is in keeping with our study in which fasting insulin levels were not associated with future weight gain, but poor ®rst-phase insulin secretion was associated with an increased weight gain. The association between fasting insulin and the change in WHR in women aged over 50 y is compatible with an effect of hormonal status on the distribution of adiposity. The rate of accumulation of visceral fat is greatest in those women with fasting hyperinsulinaemia, suggesting that either insulin resistance itself, or a factor associated with it, is causally linked to deposition of fat intra-abdominally. As women with high levels of visceral obesity are at risk of developing type 2 diabetes mellitus and coronary artery disease, these ®ndings could assist in the identi®cation of individuals at increased risk of these and other associated disorders.
